WELCOME TO

DECISION DOC MX

DATA DRIVEN PATIENT ACQUISITION

BENEFITS OF MAXIMUM DATA

Doctors learn the most about new patients from first visit

More data helps practice better medicine

Better long term care of patients

PAINS OF NEW PATIENT MARKETING

Struggle of finding new patients (average marketing company brings in 30 a month)

What if you could pay per new patient that walks in? How much would you pay?

TRADITIONAL MARKETING TACTICS

What patients see as the difference between doctors

University

Experience

Services

THE TM-FLOW MEDICAL DEVICE

TM-Flow ANS Testing Medical Device Is A Highly Comprehensive, User-friendly, Non-invasive Tool That Focuses On Early Detection And Follow-up Of Complications (Autonomic Nervous System & Vascular System) By Measuring 8 Health Risk Areas Within The Body. This ANS Testing Medical Device Effectively Measures The State Of A Patient’s Health By Screening For Hidden Causes Of Disease And Other Chronic Metabolic Diseases Such As Diabetes And Other Cardiometabolic Risks.

THIS EXAM IS PAID OUT BY MEDICARE AND MOST PRIVATE INSURANCE

The TM-Flow exam reimburses through Medicare and most private insurances. Reimbursements average between $300 to $500 per test leading to a significant increase in practice revenue. Each exam can be completed within a 15 to 20 minute scheduled event thus allowing practices the ability to do between 2 to 3 tests per hour. With a healthy internal and digital marketing strategy, we can help get your schedule filled!

THE SCIENCE OF OUR PLATFORM INCORPORATES TWO TECHNOLOGIES FOR MANAGEMENT OF OUR PROGRAMS

ANS Testing
Diagnostic Management
Encounter Form Preparation
New Patient Marketing

BIO-DATA ANALYSIS AND REIMBURSEMENT

In addition to all of the data given from the subjective intake process, we add the objective findings of the 65 ICD + modifiers of the TM-Flow. This exam analysis:

Autonomic Nervous System

Macro-vascular system

Micro-vascular system

This medical device validates over 120 bio-markers with specified CPT and ICD-10 codes reimbursable through most insurance carriers.

The codes this device use are 95923-95943-95921 and also use cardiometabolic code: 93923-93922

EARLY DETECTION AND PREVENTION

This is good medicine and will aid in the early detection of over 20 disease complications, while also validating critical next-step treatment and testing!

Heart Attack
Heart Rate Variability Issues
Cardiac Output to Body Surface Area
Abnormal LDL Cholesterol
Insulin Resistance
Diabetes with Complications
Physical and Mental Stress
Anxiety and Fatigue
Stroke
Angiotensin Activity
Atherosclerosis
Peripheral Vascular Disease
Hyperhidrosis and Hypohidrosis
Impaired Glucose Intolerance
Nerve Damage
Obesity
Amyloid Neuropathy
Asthma
Cardiovascular Associated Diseases
Idiopathic Neuropathy
Multiple System Dystrophy
Post-Partum Dysfunctions
Psychological Conditions
Pure Autonomic Failure
Sjogren’s Syndrome
ANS Testing
Diagnostic Management
Encounter Form Preparation
New Patient Marketing

THE 8 RISK FACTOR AREAS EXAMINED

Autonomic Nervous
System Dysfunction
#
Insulin Resistance
#
Endothelial
Dysfunction
#
Sudomotor
Dysfunction
#
Cardiac Autonomic
Neuropathy
#
Cardio - Metabolic
Risk
#
Small Fibre
Neuropathy
#
Cardio-vascular
Disease
SCL_lists_img8
#

Please reference the sample patient exam and the science report for a deeper dive into the clinical applications.

HEALTH RISK FACTORS DEFINED

This is good medicine and will aid in the early detection of over 20 disease complications, while also validating critical next-step treatment and testing!

1. AUTONOMOUS NERVOUS SYSTEM DYSFUNCTION RISK - ANSD

Problems with the ANS can range from mild to life-threatening. Sometimes, only one part of the nervous system is affected. In other cases, the entire ANS is affected. Some conditions are temporary and can be reversed, while others are chronic and will continue to worsen over time. Diseases such as Diabetes or Parkinson’s Disease can cause irregularities with ANS. Problems with ANS regulation often involve organ failure, or the failure of the nerves to transmit a necessary signal.

2. SUDOMOTOR DYSFUNCTION RISK - SudoD

Sudomotor dysfunction testing may indicate to physicians a patient's peripheral nerve and cardiac sympathetic dysfunction. Neuropathy is a common complication in diabetes mellitus (DM), with 60%-70% of patients affected over their lifetime. Symptoms of neuropathy is more common than clinical neuropathy. Neuropathy may remain undetected, and progress over time leading to serious complications. The most common associated clinical condition is peripheral neuropathy, affecting the feet. Autonomic nerve involvement is common but probably the most undiagnosed. Low scores in the sudomotor may lead a medical provider to look at clinical neuropathy.

3. ENDOTHELIAL DYSFUNCTION RISK - EndoD

Current evidence suggests that endothelial function is an integrative marker of the net effects of damage from traditional and emerging risk factors on the arterial wall and its intrinsic capacity for repair. Endothelial dysfunction, detected as the presence of reduced vasodilating response to endothelial stimuli, has been observed to be associated with major cardiovascular risk factors, such as aging, hyperhomocysteinemia, post menopause state, smoking, diabetes, hypercholesterolemia, and hypertension.

4. INSULIN RESISTANCE RISK - IR

Insulin resistance is defined clinically as the inability of a known quantity of exogenous or endogenous insulin to increase glucose uptake and utilization in an individual as much as it does in a normal population. Insulin resistance occurs as part of a cluster of cardiovascular metabolic abnormalities commonly referred to as "The Insulin Resistance Syndrome" or "The Metabolic Syndrome". This cluster of abnormalities may lead to the development of type 2 diabetes, accelerated atherosclerosis, hypertension or polycystic ovarian syndrome depending on the genetic background of the individual developing the insulin resistance.

HEALTH RISK FACTORS DEFINED

Here is a quick review of the health risk factors that the Dicision Doc AI Medical Device Platform report is based on.

5. CARDIOMETABOLIC RISK - CMR

The specific factors that can cause this increased risk include: obesity (particularly central), hyperglycemia, hypertension, insulin resistance and dyslipoproteinemia. When patients have one or more risk factors and are physically inactive or smoke, the cardiometabolic risk is increased even more. Medical conditions that often share the above characteristics, such as type 2 diabetes, can also increase cardiometabolic risk. The primary focus of cardiometabolic risk treatment is management of each high risk factor, including dyslipoproteinemia, hypertension, and diabetes. The management of these subjects are based principally on life style measures, but various antihypertensive, lipid-lowering, insulin sensitizing, anti-obesity and antiplatelet drugs could be helpful in reducing cardiometabolic risk.

6. PLETHYSMOGRAPHY CARDIOVASCULAR DISEASE RISK - PTG CVD

The PTG CVD risk factor is the combined total of the other seven risk factors assessments. It takes into consideration the cardiovascular as well as the autonomic nervous system (ANS) measurements.

7. CARDIAC AUTONOMIC NEUROPATHY RISK - CAN

High blood glucose levels over a period of years may cause a condition called autonomic neuropathy. This is damage to the nerves that control the regulation of involuntary function. When the nerve damage affects the heart, it is called cardiac autonomic neuropathy (CAN). CAN encompasses damage to the autonomic nerve fibers that innervate the heart and blood vessels, resulting in abnormalities in heart rate control, vascular dynamics and the body's ability to adjust blood pressure. CAN is a significant cause of morbidity and mortality associated with a high risk of cardiac arrhythmias and sudden death.

8. SMALL FIBER NEUROPATHY RISK - SFN

A small fiber neuropathy occurs when damage to the peripheral nerves predominantly or entirely affects the small myelinated fibers or unmyelinated C fibers. The specific fiber types involved in this process include both small somatic and autonomic fibers. The sensory functions of these fibers include thermal perception and nociception. These fibers are involved in many autonomic and enteric functions.

THE DICISION DOC AI MEDICAL DEVICE PLATFORM GIVES YOU A COMPLETE SOLUTION FROM PATIENT INTAKE TO ENCOUNTER FORM PREPARATION FOR BILLING.

Intake technology for validation of symptoms and medical necessity

Full TM-Flow health risk analysis display

Diagnostic conversion of Biomedical Markers from the exam into CPT and ICD language

Consolidated data on the dashboard for quick decisions and review

Encounter form preparation directly from the medical markers for billing submission

Additional qualified testing validation across 21 potential next steps

Unlimited medical devices, doctors, nurses, technicians, and other users

VALIDATION FOR ADDITIONAL NEXT STEPS TESTING

Our platform validates over 21 additional exams for potential next-steps for the physician.

INCLUDING
MRI
EEG
Blood Tests
CT Scan
NCS
A1C
Ultrasound / Vascular Studies
Thermoregulatory Sweat Tests
Angiography
Advanced ECG
Small Fiber Neuropathy Testing
Stress Tests
Chest X-Ray
Glucose Tolerance Testing
Holter Monitor
EMG
Bone Scan

Our platform Gives immediate access to the potential medical necessity for the ordering of 298+ different laboratory services found within standard Clia licensed Laboratories.

ANS Testing
Diagnostic Management
Encounter Form Preparation
New Patient Marketing

OUR NEW PATIENT MARKETING PUTS 3 TO 4 TIMES MORE MONEY INTO YOUR PRACTICE THAN ANY OTHER FIRST TIME VISIT PATIENT PROGRAM.

OUR MODEL

TM-Flow Exam $400 (National average)

Doctor time NOT required

Other New Patient Models

First Patient Visit $125

Doctor time required

AN EXAMPLE:

30 patients acquired through first time visit marketing: $3,750

30 patients acquired through the TM-Flow Health Risk Analysis:$12,000

MEDICAL INTELLIGENCE AND VALIDATION

Decision DOC AI is the central technology that empowers the rest of our software initiative in Clinical Speed. This platform was developed to give a physician the maximum visibility of a patient’s potential disease state from the subjective input at intake.

Our platform validates over 21 additional exams for potential next-steps for the physician.

There are several ways to access the evidenced data of our analysis, download patient master reports for your EHR, and a dashboard for provider quick review.

Decision DOC qualifies all of the potential CPT and ICD protocols associated with the intake qualifications. This includes research links for everything evidenced.

Our platform Gives immediate access to the potential medical necessity for the ordering of 298+ different laboratory services found within standard Clia licensed Laboratories.

Gives the intake qualifications for medical necessity to order 21 potential next steps examinations including nerve conduction studies, CAT scans, MRI, and many more.

FULLY INTEGRATED WITH THE AI DATASET OF CHATGPT 4

The Artificial Intelligence engineering world is merging with the Medial industry. We are a pioneer in this space, bringing first to market AI provider programs in treatment protocol and so much more. The AI of ChatGPT 4, the industry leading AI engine, has been fully integrated into Decision DOC AI.

Our platform generates AI for suggested treatment protocols concerning each of the initial findings mentioned in the last side generated by intake.

Our AI will generate a full list of related medications to the findings with a description of each and their benefit to the issue presented.

Our AI generates lifestyle and wellness suggestions based on the exact criteria of our intake and all other generated context.

Our AI generates example physician/patient discussions on each potential disease analysis. This gives physicians the opportunity to review and prepare to cover all necessary areas of focus in patient education.

Perspectives matter and knowing what other professionals may recommend is one of the reasons we refer patients. Our AI platform will generate opinion for most other physician taxonomies to help you decide to refer or not. Our AI engine will re-evaluate all the data from the perspective of other taxonomies for you, including Cardiology, Neurology, Oncology and several others.

Decision DOC MX solves the traditional problems of marketing with an improved first visit. Patients come in for this unique exam. Because they want the exam, all the doctor has to do is find medical necessity.

While Decision DOC AI discovers the medical necessity and intelligently presents all patient data for easy review.

DECISION DOC MX’S GOAL

150+ new patients each month

THERE ARE 2 DIFFERENT WAYS TO MARKET

Street Marketing

Web Marketing

While most companies will only do web marketing, Decision DOC MX has innovated both.

STREET MARKETING

DECISION DOC MX PERFORMS TRADITIONAL STREET MARKETING

Door Hangers
Networking Events
Etc

REWARD PROGRAM

WE REACH OUT TO LOCAL BUSINESSES TO ACQUIRE REWARD PROGRAMS

they get paid $30-$50 per patient they bring you. while mx clients build their reputations in the community

CALL CENTER DIAL IN

Each reward partner is granted a vanity number that their clients can use to call into the Decision Doc MX call center. We schedule the appointment

Call in appointments set up over the phone are $10.50each

WEB MARKETING

Referrals are still the best way to bring new patients into your practice. Online referrals also boost your website visibility more than any other action.

Social Advo is an online advocate program

Automatic postings on Facebook, X, and LinkedIn
YouTube Testimonials

Press Releases

Business Developers will write a free press release every week about your practice

SOCIAL ADVO’S POWER

Average Facebook post is seen by 12% of friends (techcrunch)

5 Social Advo partners that post once a week

40.56 * 5 =202.8 * 4.3 (weeks in a month) = 872.04 * 12 =10464.48 Impressions in 1 year

INLAND EMPIRE EXAMPLE

OUR PARTNER IN INLAND EMPIRE HAD OVER 700 LOCAL BUSINESSES WITHIN A 5-MILE RADIUS.

Within 4 weeks, over 30 partners had agreed to support the TM-Flow Exam.

One insurance company agreed to bring in 50 patients a month.

PRICES

$49,000 START UP FEE

Includes TM-Flow
Social Advo Start up
Decision Doc AI

$1,500 MO AD SPEND

$10.50 TM-FLOW PREPARATION FEE

$10.50 CLIENT ACQUISITION

YouTube
Social Advo
Ad Spend
Website

$10.50 PER CALL CENTER APPLICATION

$5 DECISION DOC AI SUBMISSION FEE

BUSINESS DEVELOPMENT

THIS IS A REQUIREMENT OF OUR MX CLIENTS WHICH REALLY MEANS THIS PROGRAM IS JUST FOR SERIOUS PLAYERS

25% over payroll + employer fees on a $25 per hr business manager on a minimum 6 month contract.

1 location 20 hrs wk.
2nd+ an additional 10 hrs wk.

Must have an onsite person that can do up to two events a month

WE ONLY WANT SERIOUS PLAYERS

DECISION DOC MX IS THE ULTIMATE NEW PATIENT ACQUISITION MODEL.

It requires replacing your current intake process with Decision DOC AI and for a practice to prepare to scale to 150+ new patients a month.

SERIOUS PARTNERS ONLY